Education
About Us
Working with TipRanks
Follow Us
China Health Group Inc. (HK:8225)
:8225
8225 Stock Chart & Stats
HK$0.14
<HK$0.01(2.58%)
At close: 4:00 PM EST
HK$0.14
<HK$0.01(2.58%)
Day’s Range― - ―
52-Week RangeHK$0.13 - HK$0.20
Previous CloseN/A
Volume40.00K
Average Volume (3M)266.67K
Market Cap
HK$143.33M
Enterprise ValueHK$101.26M
Total Cash (Recent Filing)HK$25.43M
Total Debt (Recent Filing)HK$0.00
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding995,351,700
10 Day Avg. Volume154,000
30 Day Avg. Volume266,666
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)2.64
Price to Sales (P/S)7.03
P/FCF Ratio21.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe strong revenue rebound in 2024 indicates potential recovery and growth, suggesting improved market conditions and business execution.
Cash Flow ImprovementImproved cash flow in 2024 enhances financial flexibility and indicates better cash management, which is crucial for sustaining operations.
Low Debt LevelsA low-debt balance sheet reduces solvency risk and provides financial stability, allowing the company to focus on operational improvements.
Bears Say
High Earnings VolatilityPersistent earnings volatility and losses indicate execution risks and challenge long-term profitability, impacting investor confidence.
Negative ProfitabilityOngoing losses and negative margins highlight structural profitability issues, which could hinder future growth and investment potential.
Equity ErosionDeclining equity due to cumulative losses weakens the financial foundation, posing risks to long-term stability and shareholder value.
8225 FAQ
What was China Health Group Inc.’s price range in the past 12 months?
China Health Group Inc. lowest stock price was HK$0.13 and its highest was HK$0.20 in the past 12 months.
What is China Health Group Inc.’s market cap?
China Health Group Inc.’s market cap is HK$143.33M.
When is China Health Group Inc.’s upcoming earnings report date?
China Health Group Inc.’s upcoming earnings report date is Mar 31, 2026 which is in 58 days.
How were China Health Group Inc.’s earnings last quarter?
Currently, no data Available
Is China Health Group Inc. overvalued?
According to Wall Street analysts China Health Group Inc.’s price is currently Overvalued.
Does China Health Group Inc. pay dividends?
China Health Group Inc. does not currently pay dividends.
What is China Health Group Inc.’s EPS estimate?
China Health Group Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Inc. have?
China Health Group Inc. has 995,351,700 shares outstanding.
What happened to China Health Group Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of China Health Group Inc.?
Currently, no hedge funds are holding shares in HK:8225
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Health Group Inc.
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Technical Analysis
Life Healthcare Group
―
Meihao Medical Group Co., Ltd.
―
Mediwelcome Healthcare Management & Technology Inc.
―
Bamboos Health Care Holdings Ltd
―
Huakang Biomedical Holdings Company Limited
―